Androgen receptor activity in T cells limits checkpoint blockade efficacy

X Guan, F Polesso, C Wang, A Sehrawat, RM Hawkins… - Nature, 2022 - nature.com
Immune checkpoint blockade has revolutionized the field of oncology, inducing durable anti-
tumour immunity in solid tumours. In patients with advanced prostate cancer …

Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion

SJ Han, P Jain, Y Gilad, Y Xia, N Sung… - Proceedings of the …, 2023 - National Acad Sciences
Steroid receptor coactivator 3 (SRC-3) is most strongly expressed in regulatory T cells
(Tregs) and B cells, suggesting that it plays an important role in the regulation of Treg …

Cholesterol esterification inhibition suppresses prostate cancer metastasis by impairing the Wnt/β-catenin pathway

HJ Lee, J Li, RE Vickman, J Li, R Liu, AC Durkes… - Molecular Cancer …, 2018 - AACR
Dysregulation of cholesterol is a common characteristic of human cancers including prostate
cancer. This study observed an aberrant accumulation of cholesteryl ester in metastatic …

[HTML][HTML] A humanized monoclonal antibody targeting extracellular nicotinamide phosphoribosyltransferase prevents aggressive prostate cancer progression

BL Sun, L Tang, X Sun, AN Garcia, SM Camp… - Pharmaceuticals, 2021 - mdpi.com
Prostate cancer (PCa) is the major cause of cancer-related death in males; however,
effective treatments to prevent aggressive progression remain an unmet need. We have …

[HTML][HTML] Comparative study of subcutaneous and orthotopic mouse models of prostate cancer: vascular perfusion, vasculature density, hypoxic burden and BB2r …

W Zhang, W Fan, S Rachagani, Z Zhou, SM Lele… - Scientific reports, 2019 - nature.com
The gastrin-releasing peptide receptor (BB2r) is overexpressed in a variety of cancers
including prostate cancer. As a consequence, the development of BB2r-targeted …

[HTML][HTML] Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5

W Al-Jameel, X Gou, SS Forootan, MS Al Fayi… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Castration resistant-prostate cancer is largely impervious to feather hormonal therapy and
hence the outlook for patients is grim. Here we use an approach to attach the recently …

Experimental models of bone metastasis: opportunities for the study of cancer dormancy

MCS Khoon - Advanced drug delivery reviews, 2015 - Elsevier
Skeletal metastasis is prevalent in many cancers, and has been the subject of intense
research, yielding innovative models to study the multiple stages of metastasis. It is now …

[HTML][HTML] Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ

W Al-Jameel, X Gou, X Jin, J Zhang, Q Wei, J Ai… - Genes & …, 2019 - ncbi.nlm.nih.gov
Previous study has suggested that the FABP5-PPARγ-signalling transduction pathway
gradually replaces the androgen receptor activated pathway in promoting malignant …

Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study

GD Nuyts, E Van Vlem, A De Vos… - Nephrology Dialysis …, 1995 - academic.oup.com
Wegener granulomatosis is a rare disease of unknown aetiology. In the majority of these
patients the kidney is involved in the disease process. We performed a case-control study to …

[HTML][HTML] Precision therapeutic targeting of human cancer cell motility

L Xu, R Gordon, R Farmer, A Pattanayak… - Nature …, 2018 - nature.com
Increased cancer cell motility constitutes a root cause of end organ destruction and mortality,
but its complex regulation represents a barrier to precision targeting. We use the unique …